Parallel Advisors’s CERo Therapeutics CERO Stock Holding History

Parallel Advisors’s Portfolio CERO Stock Details CERO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-121,000	Closed	-$616K	–	3773
2025 Q3	$616K	Sell	121,000 -99,000	-45%	-$728K	0.01%	585
2025 Q2	$2.12M	Buy	220,000 +209,000	+1,900%	+$2.6M	0.04%	263
2025 Q1	$161K	Buy	+11,000	New	+$435K	﹤0.01%	1048

Parallel Advisors's CERO Position: Q4 2025 in Review

Parallel Advisors sold out of CERo Therapeutics (CERO) in Q4 2025, closing a stake of 121,000 shares — an estimated $616K sold.

Parallel Advisors first reported a position in CERO in Q1 2025 and held it in 3 quarters. The position peaked at $2.12M in Q2 2025. 0 funds tracked by Wall St. Rank hold CERO as of Q4 2025.

Parallel Advisors reported no remaining CERo Therapeutics position as of Q4 2025 after selling out during the quarter.
Parallel Advisors sold 121,000 CERo Therapeutics shares in Q4 2025, an estimated $616K.
Parallel Advisors first reported a position in CERo Therapeutics in Q1 2025 and held it in 3 quarters.
Parallel Advisors's CERo Therapeutics position peaked at $2.12M in Q2 2025.
0 funds tracked by Wall St. Rank held CERo Therapeutics as of Q4 2025.

Based on Parallel Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.